Cleveland Clinic researchers pursue answers on basic science and clinical fronts
New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues
New research focuses on tumorigenic aspects of communication among brain cells
Study demonstrates its role in tumor lethality, raises prospect of therapeutic targets
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Can T-cell immunophenotyping help inform treatment decisions?
Intracranial injection of supercharged immune cells proceeds to phase 2 testing
BACE1 inhibitor reduces cancer progression in models of glioblastoma
Findings implicate hydrogen sulfide dysfunction, point to potential treatment strategies
Inhibition of DNA-PK suppresses tumor growth in preclinical models
Pairing low-frequency ultrasound with microbubble resonators to penetrate the blood-brain barrier